Bija Ventures
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Bija Ventures.
Key people at Bija Ventures.
Bija Ventures is an angel syndicate and early-stage venture fund that leverages founder-operator expertise to invest primarily in biotech and deep tech startups. It focuses on pre-seed to Series A rounds, typically investing up to $500,000 to support pioneering companies scaling breakthrough innovations. The firm aims to fuel the ascent of tech and biotech pioneers by backing startups at the earliest stages of development, thereby playing a critical role in nurturing cutting-edge innovation within these sectors[1][4].
Founded by partners including Colin Maraganore and Nelly Weiser, Bija Ventures emerged with a mission to combine deep operational experience with capital to back transformative biotech and deep tech startups. While the exact founding year is not explicitly stated, the firm has evolved to focus on pre-seed and seed investments, emphasizing founder-operator insight to identify and support promising ventures. Its dual presence in San Francisco and Aspen reflects a strategic positioning within key innovation hubs[1][4].
Bija Ventures rides the wave of increasing interest and investment in biotech and deep tech, sectors that are experiencing rapid technological advances and growing market demand. The timing is significant as breakthroughs in areas like synthetic biology, advanced therapeutics, and deep tech hardware/software integration are accelerating. By focusing on early-stage companies, Bija Ventures helps bridge the funding gap that often exists in these capital-intensive and technically complex fields, thereby influencing the broader ecosystem by enabling innovation that can lead to new industries and solutions[1][4].
Looking ahead, Bija Ventures is well-positioned to capitalize on the expanding frontier of biotech and deep tech innovation. Trends such as AI-driven drug discovery, gene editing, and sustainable technologies will likely shape their investment focus. As these sectors mature, Bija Ventures’ early bets could translate into significant impact and returns, reinforcing its role as a key enabler of next-generation technology pioneers. Their continued emphasis on founder-operator expertise and early-stage support will remain a critical differentiator in a competitive venture landscape[1][4].
Key people at Bija Ventures.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2021 | Fauna Bio | $9.0M Seed | — | Lifeforce Capital |
